[Current trends in the therapy of the shock].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001794:Blood Pressure; D001810:Blood Volume; D006801:Humans; D006931:Hyperbaric Oxygenation; D007036:Hypothermia, Induced; D008353:Mannitol / Q000627:therapeutic use; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis; D012769:Shock / Q000503:physiopathology / Q000628:therapy*; D012964:Sodium / Q000097:blood; D014692:Ventilation-Perfusion Ratio; D012122:Ventilators, Mechanical
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D008353:Mannitol; D012964:Sodium; D011188:Potassium
Stato attuale della terapia dello shock.